Christine Lee Fox
Corporate Officer/Principal chez TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Profil
Christine Lee Fox is currently the Executive Vice President-US Commercial at Teva Pharmaceutical Industries Ltd.
Prior to this, she worked as a Director at Amgen Ltd.
and as the Global President-Gene Therapies at Novartis AG.
Postes actifs de Christine Lee Fox
| Sociétés | Poste | Début |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 17/11/2023 |
Anciens postes connus de Christine Lee Fox
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Amgen Ltd.
Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
